Respiratory Medicine
Volume 101, Issue 10 , Pages 2125-2132 , October 2007

Hypoxia-induced pulmonary hypertension: Different impact of iloprost, sildenafil, and nitric oxide

  • Norbert Weissmann

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +496419942422; fax: +496419942419.
    • ,
  • Boris Gerigk

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Özlem Kocer

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Matthias Nollen

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Sascha Hackemack

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Hossein Ardeschir Ghofrani

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Ralph Theo Schermuly

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Ghazwan Butrous

      Affiliations

    • Pfizer Global Research and Development Sandwich Laboratories, Sandwich, UK
    • ,
  • Andreas Schulz

      Affiliations

    • Schering Deutschland, Berlin, Germany
    • ,
  • Markus Roth

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Werner Seeger

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany
    • ,
  • Friedrich Grimminger

      Affiliations

    • University of Giessen Lung Center (UGLC), Medical Clinic II/V, Justus-Liebig University Giessen, Klinikstrasse 36, 35392 Giessen, Germany

Received 29 January 2007 ,Accepted 20 May 2007.

References 

  1. Durmowicz AG, Stenmark KR. Mechanisms of structural remodeling in chronic pulmonary hypertension. Pediatr Rev. 1999;20(11):e91–e102
  2. Shimoda LA, Sham JS, Sylvester JT. Altered pulmonary vasoreactivity in the chronically hypoxic lung. Physiol Res. 2000;49(5):549–560
  3. Jeffery TK, Wanstall JC. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther. 2001;92(1):1–20
  4. Weissmann N, Nollen M, Gerigk B, Ardeschir GH, Schermuly RT, Gunther A, et al. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide. Am J Physiol Heart Circ Physiol. 2003;284(3):H931–H938
  5. Geraci MW, Gao B, Shepherd DC, Moore MD, Westcott JY, Fagan KA, et al. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J Clin Invest. 1999;103(11):1509–1515
  6. Kouyoumdjian C, Adnot S, Levame M, Eddahibi S, Bousbaa H, Raffestin B. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J Clin Invest. 1994;94(2):578–584
  7. Horstman DJ, Frank DU, Rich GF. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats. Anesth Analg. 1998;86(1):74–81
  8. Zhao L, Mason NA, Morrell NW, Kojonazarov B, Sadykov A, Maripov A, et al. Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation. 2001;104(4):424–428
  9. Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity. Circulation. 2003;107(2):234–237
  10. Phillips PG, Long L, Wilkins MR, Morrell NW. Cyclic AMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogues in hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol. 2005;288(1):L103–L115
  11. Sebkhi A, Strange JW, Phillips SC, Wharton J, Wilkins MR. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension. Circulation. 2003;107(25):3230–3235
  12. Griffiths MJ, Evans TW. Inhaled nitric oxide therapy in adults. N Engl J Med. 2005;353(25):2683–2695
  13. Hermle G, Schutte H, Walmrath D, Geiger K, Seeger W, Grimminger F. Ventilation-perfusion mismatch after lung ischemia-reperfusion. Protective effect of nitric oxide. Am J Respir Crit Care Med. 1999;160(4):1179–1187
  14. Walmrath D, Schermuly R, Pilch J, Grimminger F, Seeger W. Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J. 1997;10(5):1084–1092
  15. Schermuly RT, Inholte C, Ghofrani HA, Gall H, Weissmann N, Weidenbach A, et al. Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors. Respir Res. 2005;6:76
  16. Schermuly RT, Kreisselmeier KP, Ghofrani HA, Samidurai A, Pullamsetti S, Weissmann N, et al. Antiremodeling effects of iloprost and the dual-selective phosphodiesterase 3/4 inhibitor tolafentrine in chronic experimental pulmonary hypertension. Circ Res. 2004;94(8):1101–1108
  17. Weissmann N, Grimminger F, Walmrath D, Seeger W. Hypoxic vasoconstriction in buffer-perfused rabbit lungs. Respir Physiol. 1995;100(2):159–169
  18. Weissmann N, Grimminger F, Voswinckel R, Conzen J, Seeger W. Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs. Am J Physiol. 1998;274(5 Pt 1):L721–L727
  19. Weissmann N, Voswinckel R, Hardebusch T, Rosseau S, Ghofrani HA, Schermuly R, et al. Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction. Am J Physiol. 1999;276(1 Pt 1):L90–L95
  20. Weissmann N, Tadic A, Hanze J, Rose F, Winterhalder S, Nollen M, et al. Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H(2)O(2)?. Am J Physiol Lung Cell Mol Physiol. 2000;279(4):L683–L690
  21. Spriestersbach R, Grimminger F, Weissmann N, Walmrath D, Seeger W. On-line measurement of nitric oxide generation in buffer-perfused rabbit lungs. J Appl Physiol. 1995;78(4):1502–1508
  22. Ozaki M, Kawashima S, Yamashita T, Ohashi Y, Rikitake Y, Inoue N, et al. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium. Hypertension. 2001;37(2):322–327
  23. Grimminger F, Spriestersbach R, Weissmann N, Walmrath D, Seeger W. Nitric oxide generation and hypoxic vasoconstriction in buffer-perfused rabbit lungs. J Appl Physiol. 1995;78(4):1509–1515
  24. Sauzeau V, Rolli-Derkinderen M, Lehoux S, Loirand G, Pacaud P. Sildenafil prevents change in RhoA expression induced by chronic hypoxia in rat pulmonary artery. Circ Res. 2003;93(7):630–637
  25. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Dekkers DH, Duncker DJ, et al. Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy. Proteomics. 2005;5(10):2519–2530
  26. Adachi S, Ito H, Ohta Y, Tanaka M, Ishiyama S, Nagata M, et al. Distribution of mRNAs for natriuretic peptides in RV hypertrophy after pulmonary arterial banding. Am J Physiol. 1995;268(1 Pt 2):H162–H169
  27. Takimoto E, Champion HC, Li M, Belardi D, Ren S, Rodriguez ER, et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med. 2005;11(2):214–222
  28. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P. Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res. 2005;97(2):185–191
  29. Frank DU, Horstman DJ, Rich GF. The effect of prolonged inhaled nitric oxide on pulmonary vasoconstriction in rats. Anesth Analg. 1998;87(6):1285–1290
  30. Higenbottam TW, Butt AY, Nh-Xaun AT, Takao M, Cremona G, Akamine S. Treatment of pulmonary hypertension with the continuous infusion of a prostacyclin analogue, iloprost. Heart. 1998;79(2):175–179
  31. Schermuly RT, Yilmaz H, Ghofrani HA, Woyda K, Pullamsetti S, Schulz A, et al. Inhaled iloprost reverses vascular remodeling in chronic experimental pulmonary hypertension. Am J Respir Crit Care Med. 2005;172(3):358–363

☆ This work was supported by the Deutsche Forschungsgemeinschaft, SFB 547, project B7.

PII: S0954-6111(07)00221-1

doi: 10.1016/j.rmed.2007.05.025

Respiratory Medicine
Volume 101, Issue 10 , Pages 2125-2132 , October 2007

Article Tools

* Image Usage & Resolution